Cargando…

Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening

The cAMP-responsive element binding protein (CREB) binding protein (CBP) and adenoviral E1A-binding protein (P300) are two closely related multifunctional transcriptional coactivators. Both proteins contain a bromodomain (BrD) adjacent to the histone acetyl transferase (HAT) catalytic domain, which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Feng-cai, Sun, Zhong-ya, Liao, Li-ping, Zuo, Yu, Zhang, Dan, Wang, Jun, Chen, Yan-tao, Xiao, Sen-hao, Jiang, Hao, Lu, Tian, Xu, Pan, Yue, Li-yan, Du, Dao-hai, Zhang, Hao, Liu, Chuan-peng, Luo, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468272/ https://www.ncbi.nlm.nih.gov/pubmed/31253937 http://dx.doi.org/10.1038/s41401-019-0256-2

Ejemplares similares

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
por: Hay, Duncan A., et al.
Publicado: (2014)

Optimization and validation of a DYRK1A TR-FRET assay for high-throughput screening
por: Tarpley, Michael, et al.
Publicado: (2021)

A protocol for high-throughput screening of histone lysine demethylase 4 inhibitors using TR-FRET assay
por: Wu, Qiong, et al.
Publicado: (2021)

SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening
por: Gorshkov, Kirill, et al.
Publicado: (2022)

A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening
por: Gorshkov, Kirill, et al.
Publicado: (2021)

CBP/p300 Bromodomain Inhibitor–I–CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs
por: Strachowska, Magdalena, et al.
Publicado: (2021)

Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain
por: Chaikuad, Apirat, et al.
Publicado: (2016)

CBP Bromodomain Inhibition Rescues Mice From Lethal Sepsis Through Blocking HMGB1-Mediated Inflammatory Responses
por: Bi, Xiaowen, et al.
Publicado: (2021)

CBP/p300 Bromodomains Regulate Amyloid-like Protein Aggregation upon Aberrant Lysine Acetylation
por: Olzscha, Heidi, et al.
Publicado: (2017)

Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 Phosphorylation
por: Hermanson, Spencer B., et al.
Publicado: (2012)

Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancer
por: Hogg, Simon J., et al.
Publicado: (2022)

Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery
por: Fu, Lei-lei, et al.
Publicado: (2015)

Single-Peptide TR-FRET Detection Platform for Cysteine-Specific Post-Translational Modifications
por: Eskonen, Ville, et al.
Publicado: (2020)

Discovery of a PCAF Bromodomain Chemical Probe
por: Moustakim, Moses, et al.
Publicado: (2016)

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

Discovery and characterization of bromodomain 2–specific inhibitors of BRDT
por: Yu, Zhifeng, et al.
Publicado: (2021)

Targeting bromodomain-containing proteins: research advances of drug discovery
por: Pan, Zhaoping, et al.
Publicado: (2023)

TR-FRET-Based Immunoassay to Measure Ataxin-2 as a Target Engagement Marker in Spinocerebellar Ataxia Type 2
por: Bux, Jessica, et al.
Publicado: (2023)

Targeting protein-protein interactions for therapeutic discovery via FRET-based high-throughput screening in living cells
por: Stroik, Daniel R., et al.
Publicado: (2018)

Quantifying autophagy using novel LC3B and p62 TR-FRET assays
por: Bresciani, Alberto, et al.
Publicado: (2018)

SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET
por: Cecon, Erika, et al.
Publicado: (2022)

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
por: Conery, Andrew R, et al.
Publicado: (2016)

Drug Discovery Targeting Bromodomain-Containing Protein 4
por: Liu, Zhiqing, et al.
Publicado: (2017)

Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis
por: Fu, Rong, et al.
Publicado: (2022)

Discovery of Benzo[d]imidazole‐6‐sulfonamides as Bromodomain and Extra‐Terminal Domain (BET) Inhibitors with Selectivity for the First Bromodomain
por: Cipriano, Alessandra, et al.
Publicado: (2022)

Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery
por: Russell, Catherine N., et al.
Publicado: (2023)

Selectivity Mechanism of Pyrrolopyridone Analogues Targeting Bromodomain 2 of Bromodomain-Containing Protein 4 from Molecular Dynamics Simulations
por: Shi, Mingsong, et al.
Publicado: (2023)

Red-Shifted FRET Biosensors for High-Throughput Fluorescence Lifetime Screening
por: Schaaf, Tory M., et al.
Publicado: (2018)

TR-FRET Assays of Huntingtin Protein Fragments Reveal Temperature and PolyQ Length-Dependent Conformational Changes
por: Cui, Xiaotian, et al.
Publicado: (2014)

Identification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay
por: Watari, Akihiro, et al.
Publicado: (2017)

Detection of SARS-CoV-2 spike protein binding to ACE2 in living cells by TR-FRET
por: Cecon, Erika, et al.
Publicado: (2021)

A FRET-based high-throughput screening platform for the discovery of chemical probes targeting the scaffolding functions of human tankyrases
por: Sowa, Sven T., et al.
Publicado: (2020)

Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements
por: Yu, Dong-Shan, et al.
Publicado: (2018)

Corrigendum: Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements
por: Yu, Dong-Shan, et al.
Publicado: (2020)

Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022)

Development of FRET Assay into Quantitative and High-throughput Screening Technology Platforms for Protein–Protein Interactions
por: Song, Yang, et al.
Publicado: (2010)

The Use of the LanthaScreen TR-FRET CAR Coactivator Assay in the Characterization of Constitutive Androstane Receptor (CAR) Inverse Agonists
por: Carazo, Alejandro, et al.
Publicado: (2015)

Structure of CbpA J-Domain Bound to the Regulatory Protein CbpM Explains Its Specificity and Suggests Evolutionary Link between CbpM and Transcriptional Regulators
por: Sarraf, Naghmeh S., et al.
Publicado: (2014)

A high-throughput FRET-based assay for determination of Atg4 activity
por: Li, Min, et al.
Publicado: (2012)

Molecular dynamics simulations data of six compounds F3J-BRD4/CBP, EX1-BRD4/CBP, and E2T-BRD4/CBP
por: Wu, Shiliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3c7emg41ugcls0cigjkr4imrs6